Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Published in: Cancer and Metastasis Reviews 2/2006

01-06-2006

Molecular mechanisms of metastasis

Authors: Dave S. B. Hoon, Minoru Kitago, Joseph Kim, Takuji Mori, Adriano Piris, Katherine Szyfelbein, Martin C. Mihm Jr., S. David Nathanson, Timothy P. Padera, Ann F. Chambers, Sharon A. Vantyghem, Ian C. MacDonald, Steven C. Shivers, Marwan Alsarraj, Douglas S. Reintgen, Bernward Passlick, Wulf Sienel, Klaus Pantel

Published in: Cancer and Metastasis Reviews | Issue 2/2006

Login to get access
Metadata
Title
Molecular mechanisms of metastasis
Authors
Dave S. B. Hoon
Minoru Kitago
Joseph Kim
Takuji Mori
Adriano Piris
Katherine Szyfelbein
Martin C. Mihm Jr.
S. David Nathanson
Timothy P. Padera
Ann F. Chambers
Sharon A. Vantyghem
Ian C. MacDonald
Steven C. Shivers
Marwan Alsarraj
Douglas S. Reintgen
Bernward Passlick
Wulf Sienel
Klaus Pantel
Publication date
01-06-2006
Publisher
Kluwer Academic Publishers
Published in
Cancer and Metastasis Reviews / Issue 2/2006
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-006-8500-x

Other articles of this Issue 2/2006

Cancer and Metastasis Reviews 2/2006 Go to the issue

OriginalPaper

Individualized therapy of disseminated cancer using malignant melanoma as a model

OriginalPaper

Experimental frontiers for clinical applications: Novel approaches to understanding mechanisms of lymph Node metastases in melanoma

OriginalPaper

Introduction

OriginalPaper

Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents

OriginalPaper

Future perspectives for cancer metastasis and the lymphovascular system

OriginalPaper

Immune responses in the draining lymph nodes against cancer: Implications for immunotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits